MENU

IEEE PULSE Interview with Adaptyx CEO: Next-Gen Wearable Biosensors and AI Health Insights Drive Future of Personalized Healthcare

Facebook (IEEE PULSE) USA
Overview
In an IEEE PULSE Industry Corner interview, Vijit Sabnis, Co-Founder and CEO of Adaptyx, discussed next-generation wearable biosensors, AI-powered health insights, and innovations driving personalized healthcare. Sabnis highlighted the evolution of diverse wearable health technologies, including smartwatches, flexible wrist patches, smart glasses, contact lenses, smart clothing, and epidermal biosensors. These devices monitor biomarkers like glucose, heart rate, sweat ions, and cortisol, with applications ranging from managing Parkinson’s disease, atrial fibrillation, and diabetes to optimizing athlete performance.
In Depth

Key Findings

In an ‘Industry Corner’ interview with IEEE PULSE, Vijit Sabnis, Co-Founder and CEO of Adaptyx, shared insights into how next-generation wearable biosensors and AI-powered health insights are shaping the future of personalized healthcare. Sabnis highlighted the advancements in a diverse range of innovative wearable health technologies, including smartwatches, flexible wrist patches, smart glasses, contact lenses, smart clothing, and epidermal biosensors. He emphasized these devices’ capability for real-time, high-accuracy monitoring of biomarkers such as glucose, heart rate, sweat ions, and the stress hormone cortisol. This opens up broad applications, from personalized care for chronic conditions like Parkinson’s disease, atrial fibrillation, and diabetes management, to optimizing athlete performance.

Technical and Clinical Details

According to Sabnis, wearable biosensors are undergoing diverse evolutions in both form and functionality. Specifically:

  • Smartwatches: Integrate optical sensors to non-invasively track multiple physiological parameters, including estimated glucose levels, Parkinson’s tremors, and atrial fibrillation detection.
  • Wrist Patches: Adhere flexibly to the skin and analyze chemical substances in sweat like sodium, lactate, and cortisol to monitor hydration status, fatigue, and stress levels.
  • Smart Glasses/Contact Lenses: Explore the potential for non-invasive glucose monitoring for diabetic patients by measuring glucose in tear fluid.
  • Smart Clothing/e-textiles: Directly embed sensors into garments to continuously track respiration rate, heart rate, body temperature, posture, and movement, providing comprehensive health data in daily life.
  • Epidermal Biosensors: Function as thin patches or ‘electronic tattoos’ applied directly to the skin, offering high-accuracy, real-time measurement of sweat biomarkers such as glucose, sodium, and lactate. Specific disease diagnostic applications, like measuring sweat chloride ions for cystic fibrosis diagnosis, are also anticipated.
  • Saliva-Based Sensors: Graphene-based sensors or Bluetooth-enabled mouthguards worn in the oral cavity analyze biomarkers like glucose and uric acid in saliva.

The vast data obtained from these sensors is analyzed by AI/machine learning algorithms to generate ‘AI-powered health insights’ tailored to individual health conditions. This enables the early identification of anomalous health patterns and facilitates predictive diagnostics and personalized interventions.

Background and Industry Context

The healthcare industry is heavily shifting towards personalized, preventive, and patient-centric care. Wearable technology plays a central role in this transformation by enabling patients to collect and share their health data with healthcare providers in real-time. The ability to continuously monitor subtle daily health changes, which traditional periodic health check-ups often miss, is crucial for early disease detection and effective chronic disease management. Integration with AI addresses the challenge of data overload, extracting meaningful insights to support healthcare providers’ decision-making and improve the efficiency of the healthcare system. Companies like Adaptyx are at the forefront of such technological innovations, developing products that meet market needs.

Strategic Significance and Outlook

Sabnis predicts that the future of wearable biosensors will be characterized by more advanced multimodal sensing, non-invasive sampling, and seamless integration with AI. In the future, systems could measure multiple biomarkers simultaneously, combine this data with individual genetic information, lifestyle data, and environmental factors to predict disease risks, and automatically recommend preventive interventions—a ‘closed-loop’ system. This is expected to enhance patient self-management capabilities and accelerate the efficiency and personalization of the overall healthcare system. However, data privacy and security, regulatory approval, and validation through large-scale clinical trials remain critical challenges for the widespread adoption of these innovative technologies.

Source: https://www.facebook.com/ieeeembs/posts/new-from-ieee-pulse-what-does-the-future-hold-for-wearable-health-technologiesin/1474968071337450/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Let's share this post !

Author of this article

Comments

To comment

TOC